Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol

Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus

(2011) Naoya Kawano et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice

(2011) B. A. Di Bartolo et al.   DIABETOLOGIA

Association of soluble tumour necrosis factor-related apoptosis-inducing ligand levels with coronary plaque burden and composition

(2011) Spyridon Deftereos et al.   HEART

Waist Circumference, Body Mass Index, and Survival in Systolic Heart Failure: The Obesity Paradox Revisited

(2011) Adrienne L. Clark et al.   JOURNAL OF CARDIAC FAILURE

Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults

(2010) Stefano Volpato et al.   ATHEROSCLEROSIS

Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects

(2010) David T. Ashley et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Prognostic value of apoptosis markers in advanced heart failure patients

(2009) A. Niessner et al.   EUROPEAN HEART JOURNAL

Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction

(2009) Paola Secchiero et al.   PLoS One

Body mass index and mortality in heart failure: A meta-analysis

(2008) Antigone Oreopoulos et al.   AMERICAN HEART JOURNAL